Utah Medical Products Inc (UTMD) stock
Close on Nov 11, 2026Market cap $232.51MP/E 22.3Yield –
Utah Medical Products Inc reported revenue of $36.11M for the twelve months to Jun 30, 2026. Free cash flow was $11.45M. At the latest close the market valued the company at $232.51M, 22.3 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $232.51M
- P/E ratio
- 22.3
- Price to sales
- 6.44
- Price to book
- 1.91
- Dividend yield
- –
- Free cash flow yield
- 4.92%
Fundamentals
- Revenue
- $36.11M
- EPS, diluted
- $3.28
- Free cash flow
- $11.45M
- Book value per share
- $38.33
- Diluted shares
- 3M
Trading
- Next earnings
- Jan 28, 2027 (estimated, during market hours)
- Previous close
- $72.86
- Open
- $72.47
- Day's range
- $71.43 – $73.77
- Volume
- 21,914
- Average volume (20 days)
- 36,648
- Index membership
- Russell 2000, Russell 3000
- Beta (5 years)
- 0.48
- 52-week range
- $53.66 – $76.89
- RSI (14 days)
- 52.5
- Volatility (1 year)
- 28.9%
- Relative volume
- 0.63×
- WACC
- 7.4%
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | UTMD | S&P 500 | Difference | UTMD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -2.0% | -2.4% | +0.4 pts | ||
| 3 months | +1.9% | -1.2% | +3.1 pts | ||
| Year to date | +32.3% | +12.3% | +20.0 pts | ||
| 1 year | +30.1% | +12.4% | +17.7 pts | ||
| 3 years | -2.2% | +78.8% | −81.0 pts | -0.7% | +21.4% |
| 5 years | -23.6% | +75.2% | −98.8 pts | -5.3% | +11.9% |
| 10 years | +32.2% | +311.1% | −278.9 pts | +2.8% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
EPS, diluted
Free cash flow
Press releases
Releases Utah Medical Products filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Results
- Update
- Results
- Results
- Results
About Utah Medical Products
Surgical & Medical Instruments & Apparatus
Utah Medical Products, Inc. manufactures and markets specialized medical devices designed to improve patient safety and clinical outcomes. The company's products span critical care sectors, including labor and delivery, neonatal intensive care, and gynecology, electrosurgery, and urology. Offerings include fetal monitoring accessories, intrauterine pressure catheters, vacuum-assisted delivery systems, infant respiratory hoods, enteral feeding devices, and electrosurgical systems such as loop electrodes and generators. Its customers primarily consist of clinical end-user facilities, hospitals, outpatient clinics, and physician offices, alongside designated stocking distributors and medical device companies utilizing subcontract manufacturing.
Company profile, executives and historyUtah Medical Products stock: common questions
What is Utah Medical Products's stock price?
UTMD closed at $73.03 on Nov 11, 2026, up 0.23% on the day. Over the past 52 weeks it traded between $53.66 and $76.89.
What is Utah Medical Products's market cap?
Utah Medical Products was worth $232.51M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is UTMD's P/E ratio?
UTMD trades at 22.3 times earnings, based on diluted earnings per share of $3.28 over the twelve months to Jun 30, 2026.
How much revenue does Utah Medical Products make?
Utah Medical Products reported revenue of $36.11M for the twelve months to Jun 30, 2026.
Does Utah Medical Products pay a dividend?
No. Utah Medical Products has not paid a cash dividend over the last twelve months.
When does Utah Medical Products report earnings next?
Utah Medical Products is expected to report Q4 FY2026 results on Jan 28, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has UTMD stock performed over the past year?
Including dividends, UTMD returned +30.1% over the past year, against +12.4% for the S&P 500.
How many UTMD shares are sold short?
0M shares were sold short at the latest FINRA report, 5.13% of the float, or 3.9 days of average trading volume.
Who are Utah Medical Products's competitors?
Companies most similar to Utah Medical Products by business, industry and size include PLSM, BDMD, RVP, KRMD, IRMD.
See a number that looks wrong?